Drug Monitoring
"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.
Descriptor ID |
D016903
|
MeSH Number(s) |
E01.370.520.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".
Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".
This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 0 | 1 | 1 | 1994 | 0 | 1 | 1 | 1995 | 0 | 1 | 1 | 1998 | 1 | 0 | 1 | 1999 | 1 | 0 | 1 | 2003 | 0 | 1 | 1 | 2004 | 0 | 1 | 1 | 2006 | 1 | 0 | 1 | 2010 | 0 | 1 | 1 | 2012 | 0 | 2 | 2 | 2013 | 0 | 2 | 2 | 2014 | 2 | 0 | 2 | 2015 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Monitoring" by people in Profiles.
-
Fleming ML, Phan Y, Ferries EA, Hatfield MD. Educating Pharmacists on a Prescription Drug Monitoring Program. J Pharm Pract. 2016 Dec; 29(6):543-548.
-
Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels SA, Novak S. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. J Am Pharm Assoc (2003). 2014 May-Jun; 54(3):241-50.
-
Fleming ML, Hatfield MD, Wattana MK, Todd KH. Exploratory study of emergency physicians' use of a prescription monitoring program using a framework of technology acceptance. J Pain Palliat Care Pharmacother. 2014 Mar; 28(1):19-27.
-
Dawson AG, Heidari P, Gadagkar SR, Murray MJ, Call GB. An airtight approach to the inebriometer: from construction to application with volatile anesthetics. Fly (Austin). 2013 Apr-Jun; 7(2):112-7.
-
Wanat MA, Hart SR, Putney D, Liebl MG, Chandler W. Alternative monitoring of argatroban using plasma-diluted thrombin time. Ann Pharmacother. 2013 Apr; 47(4):e18.
-
Hou JK, Kramer JR, Richardson P, Sansgiry S, El-Serag HB. Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther. 2012 Dec; 36(11-12):1049-56.
-
Tran TT, Palmer HR, Weston J, Hirsch EB, Shah DN, Cottreau J, Tam VH, Garey KW. Evaluation of a daptomycin dose-optimization protocol. Am J Health Syst Pharm. 2012 Jun 01; 69(11):979-84.
-
Crutchley RD, Ma Q, Sulaiman A, Hochreitter J, Morse GD. Within-patient atazanavir trough concentration monitoring in HIV-1-infected patients. J Pharm Pract. 2011 Apr; 24(2):216-22.
-
Rezk NL, Crutchley RD, Yeh RF, Kashuba AD. Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring. Ther Drug Monit. 2006 Aug; 28(4):517-25.
-
Aparasu RR. The quality of pharmaceutical care in the elderly. S D J Med. 2004 Nov; 57(11):489-90.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|